Package 71209-006-10

{"route": ["ORAL"], "spl_id": "4c64f761-cab6-4360-9561-89b32c3ec030", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311", "197313"], "spl_set_id": ["acef88f4-6456-4092-993f-27e1496097c7"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (71209-006-05)", "package_ndc": "71209-006-05", "marketing_start_date": "20181120"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (71209-006-10)", "package_ndc": "71209-006-10", "marketing_start_date": "20181120"}], "brand_name": "Acyclovir", "product_id": "71209-006_4c64f761-cab6-4360-9561-89b32c3ec030", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71209-006", "generic_name": "Acyclovir", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA202168", "marketing_category": "ANDA", "marketing_start_date": "20170323", "listing_expiration_date": "20261231"}